Skip to main content
Raphas Co., Ltd. logo

Raphas Co., Ltd. — Investor Relations & Filings

Ticker · 214260 ISIN · KR7214260002 KO Manufacturing
Open in API
Filings indexed 325 across all filing types
Latest filing 2021-02-25 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 214260

About Raphas Co., Ltd.

https://www.raphas.com/

Raphas Co., Ltd. is a biotechnology company specializing in advanced drug delivery systems. The company develops and manufactures biodegradable, dissolving microneedles using its proprietary DEN technology, a transdermal delivery platform. This technology is applied to create patches for a range of cosmetic and therapeutic needs, including anti-aging, wrinkle reduction, whitening, and acne treatment. Raphas commercializes its products through its own cosmetics brand, Acropass, and also offers manufacturing services for custom patch development.

Recent filings

Filing Released Lang Actions
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options). It details the issuance of stock options to directors and employees, including the number of shares, exercise price, and valuation methodology. This type of disclosure regarding capital structure changes and equity-based compensation does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for general capital changes). As it is a specific regulatory disclosure required by the Financial Supervisory Service (FSS) in Korea, it falls under the 'Regulatory Filings' category.
2021-02-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the change in share ownership by an executive (Shin Ju Yeop) of the company Raphas. This type of filing is specifically for reporting insider transactions or changes in holdings by directors and executives, which corresponds to the 'Director's Dealing' category.
2021-02-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed under the Capital Markets Act in South Korea. This type of filing is used to disclose significant changes in share ownership (often referred to as the '5% rule' filing). In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2021-02-05 Korean
기타경영사항(특허권취득)(자율공시)(마이크로니들 패치를 이용한 피부 간질액 내 글루코오스 추출을 위한 최소침습적 방법)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (Raphas) announcing the acquisition of a patent. It follows the standard format for 'Other Management Matters' (기타 경영사항) under the Korean regulatory disclosure system (DART). Since it does not fit into specific categories like financial reports, board changes, or dividends, and is a formal regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2021-01-28 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the closure of the shareholder register (stock transfer suspension) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal regulatory announcement of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2020-12-14 Korean
기타경영사항(특허권취득)(자율공시)(마이크로니들 패취를 이용한 최소 침습적 피부 생체 검사 방법)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by the company Raphas. It details the patent name, content, and utilization plan. Since this is a specific regulatory announcement regarding corporate developments that does not fit into financial reporting, dividend, or management change categories, it falls under the general regulatory filing category.
2020-12-01 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.